FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945591768> ?p ?o ?g. }

• W2945591768 endingPage "468" @default.
• W2945591768 startingPage "462" @default.
• W2945591768 abstract "Introduction Individuals with chronic hepatitis B virus (HBV) infection or past exposure to HBV infection have a substantial risk of reactivation during immunosuppressive cancer therapy. HBV reactivation can lead to liver failure, cancer treatment interruption or death. Clinical concordance with screening and treatment guidelines is inconsistent in practice, and existing international guidelines are not specific to the Australian context. We developed an Australian consensus statement with infectious diseases, hepatology, haematology and oncology specialists to inform hepatitis B screening and antiviral management for immunocompromised patients with haematological and solid organ malignancies in Australia. Main recommendations Recommendations address four key areas of HBV infection management for immunocompromised patients with haematological and solid organ malignancies: who to test for HBV infection, when to start antiviral agents, when to stop antiviral agents, and how to monitor patients during cancer therapy. We recommend testing all patients undergoing cancer treatment for hepatitis B (including HBV surface antigen [HBsAg], HBV core antibody [anti-HBc], and HBV surface antibody) before cancer treatment. Individuals with chronic HBV infection (HBsAg positive) or past exposure (HBsAg negative and anti-HBc positive) receiving higher risk chemotherapy require antiviral prophylaxis using entecavir or tenofovir. Changes in management as a result of this statement This consensus statement will simplify the approach to testing and prophylaxis for HBV infection during cancer therapy, and harmonise approaches to discontinuing and monitoring individuals which have been highly variable in practice. We advocate for broader Medicare Benefits Schedule and Pharmaceutical Benefits Scheme access to HBV testing and treatment for patients undergoing cancer therapy." @default.
• W2945591768 created "2019-05-29" @default.
• W2945591768 creator A5016659008 @default.
• W2945591768 creator A5018875962 @default.
• W2945591768 creator A5023367188 @default.
• W2945591768 creator A5023605193 @default.
• W2945591768 creator A5026835706 @default.
• W2945591768 creator A5037683678 @default.
• W2945591768 creator A5044830828 @default.
• W2945591768 creator A5059321913 @default.
• W2945591768 creator A5073647747 @default.
• W2945591768 creator A5077160653 @default.
• W2945591768 creator A5085357579 @default.
• W2945591768 creator A5086610023 @default.
• W2945591768 date "2019-05-19" @default.
• W2945591768 modified "2023-09-27" @default.
• W2945591768 title "Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement" @default.
• W2945591768 cites W1827908951 @default.
• W2945591768 cites W1977303859 @default.
• W2945591768 cites W1994351795 @default.
• W2945591768 cites W2002558637 @default.
• W2945591768 cites W2005897994 @default.
• W2945591768 cites W2006361951 @default.
• W2945591768 cites W2018486374 @default.
• W2945591768 cites W2021362597 @default.
• W2945591768 cites W2031317669 @default.
• W2945591768 cites W2043712325 @default.
• W2945591768 cites W2058041473 @default.
• W2945591768 cites W2067642835 @default.
• W2945591768 cites W2083375658 @default.
• W2945591768 cites W2085997970 @default.
• W2945591768 cites W2090483140 @default.
• W2945591768 cites W2093770528 @default.
• W2945591768 cites W2095079937 @default.
• W2945591768 cites W2108827800 @default.
• W2945591768 cites W2123913599 @default.
• W2945591768 cites W2125474736 @default.
• W2945591768 cites W2126234152 @default.
• W2945591768 cites W2147134417 @default.
• W2945591768 cites W2155792443 @default.
• W2945591768 cites W2161758234 @default.
• W2945591768 cites W2164785014 @default.
• W2945591768 cites W2169265646 @default.
• W2945591768 cites W2173698250 @default.
• W2945591768 cites W2174723704 @default.
• W2945591768 cites W2222056650 @default.
• W2945591768 cites W2342291952 @default.
• W2945591768 cites W2568221317 @default.
• W2945591768 cites W2605785536 @default.
• W2945591768 cites W2648673706 @default.
• W2945591768 cites W2735235156 @default.
• W2945591768 cites W2755293930 @default.
• W2945591768 cites W4211000022 @default.
• W2945591768 cites W4242609773 @default.
• W2945591768 cites W4253465845 @default.
• W2945591768 cites W56605606 @default.
• W2945591768 doi "https://doi.org/10.5694/mja2.50160" @default.
• W2945591768 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31104328" @default.
• W2945591768 hasPublicationYear "2019" @default.
• W2945591768 type Work @default.
• W2945591768 sameAs 2945591768 @default.
• W2945591768 citedByCount "13" @default.
• W2945591768 countsByYear W29455917682019 @default.
• W2945591768 countsByYear W29455917682020 @default.
• W2945591768 countsByYear W29455917682021 @default.
• W2945591768 countsByYear W29455917682022 @default.
• W2945591768 countsByYear W29455917682023 @default.
• W2945591768 crossrefType "journal-article" @default.
• W2945591768 hasAuthorship W2945591768A5016659008 @default.
• W2945591768 hasAuthorship W2945591768A5018875962 @default.
• W2945591768 hasAuthorship W2945591768A5023367188 @default.
• W2945591768 hasAuthorship W2945591768A5023605193 @default.
• W2945591768 hasAuthorship W2945591768A5026835706 @default.
• W2945591768 hasAuthorship W2945591768A5037683678 @default.
• W2945591768 hasAuthorship W2945591768A5044830828 @default.
• W2945591768 hasAuthorship W2945591768A5059321913 @default.
• W2945591768 hasAuthorship W2945591768A5073647747 @default.
• W2945591768 hasAuthorship W2945591768A5077160653 @default.
• W2945591768 hasAuthorship W2945591768A5085357579 @default.
• W2945591768 hasAuthorship W2945591768A5086610023 @default.
• W2945591768 hasBestOaLocation W29455917682 @default.
• W2945591768 hasConcept C121608353 @default.
• W2945591768 hasConcept C126322002 @default.
• W2945591768 hasConcept C151730666 @default.
• W2945591768 hasConcept C177713679 @default.
• W2945591768 hasConcept C203014093 @default.
• W2945591768 hasConcept C2522874641 @default.
• W2945591768 hasConcept C2776175608 @default.
• W2945591768 hasConcept C2777382497 @default.
• W2945591768 hasConcept C2777410769 @default.
• W2945591768 hasConcept C2777869810 @default.
• W2945591768 hasConcept C2779343474 @default.
• W2945591768 hasConcept C2780252810 @default.
• W2945591768 hasConcept C2780593183 @default.
• W2945591768 hasConcept C71924100 @default.
• W2945591768 hasConcept C86803240 @default.
• W2945591768 hasConceptScore W2945591768C121608353 @default.
• W2945591768 hasConceptScore W2945591768C126322002 @default.

• next